COMMUNIQUÉS West-GlobeNewswire

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program
10/06/2025
NeuroStar, a Silver Sponsor at CTMSS, will also present two posters as part of the Company’s ongoing commitment to clinical innovation and excellence MALVERN. Pa., June 10, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. ( [...]
Iovance Biotherapeutics to Present at Upcoming Conference
10/06/2025
SAN CARLOS, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating [...]
Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension
10/06/2025
NORCROSS, Ga., June 10, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today [...]
Roji Health Intelligence Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity
10/06/2025
HITRUST e1 Certification validates Roji Health Intelligence is committed to foundational cybersecurity controls and information risk management CHICAGO, June 10, 2025 (GLOBE NEWSWIRE) -- Roji Health Intelligence LLC, a [...]
NeuroSigma Announces Notice of Allowance for Patent Protecting Monarch eTNS System in China
10/06/2025
LOS ANGELES, June 10, 2025 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. , a Los Angeles-based bioelectronics company commercializing the Monarch external Trigeminal Nerve Stimulation (eTNS) device for treating attention-deficit [...]
Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
10/06/2025
Study is Intended to Verify Previous Discovery Results Demonstrating Sensitivity of 95% and Specificity of 98% BERKELEY, Calif. and MAINZ, Germany, June 10, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“ [...]
Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution
10/06/2025
The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits. NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc [...]
Ernexa Therapeutics Announces 1-for-15 Reverse Stock Split
10/06/2025
CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced a reverse stock [...]
International Myeloma Foundation (IMF) to Honor 2025 Kyle and Durie Achievement Awardees, Dr. Sagar Lonial and Dr. Sonja Zweegman
10/06/2025
Awarding ceremonies to be held on June 10, 2025, at the 16th Annual IMWG Summit in Milano, Italy MILAN, June 10, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and the International Myeloma Working [...]
Tiny Health and Evexia Diagnostics Close the Gut Testing Access Gap
10/06/2025
Tiny Health and Evexia Diagnostics Expand At-Home Microbiome Testing Access Across Conventional and Functional Medicine Providers in the U.S. and Canada AUSTIN, Texas, June 10, 2025 (GLOBE NEWSWIRE) -- Over 40% of [...]
Announcing the 2025 Philadelphia Titan 100 Recipients
10/06/2025
BERWYN, Pa., June 10, 2025 (GLOBE NEWSWIRE) -- Titan CEO is pleased to announce that Bill Oldham, chairman and president, AscellaHealth , has been inducted as one of only 10 honorees into the 2025 Philadelphia Titan 100 [...]
Dogecoin Cash Inc. (OTCQB: CBDS) Announces Symbol Change to DOGP, Planting Its Flag in the Memeosphere
10/06/2025
MESQUITE, NV, June 10, 2025 (GLOBE NEWSWIRE) -- Dogecoin Cash Inc. (OTCQB: CBDS), a publicly traded company operating at the intersection of digital assets and public equity markets, announced today that it has received [...]
XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology
10/06/2025
Freising, Germany, June 10, 2025 — XL-protein GmbH, a pioneer in the area of biopolymers for pharmacokinetic optimization, announced today that it has entered into a worldwide License, Development and Commercialization [...]
HepaRegeniX Doses First Patient in Phase Ib Trial with Small Molecule Inhibitor HRX-215 to Promote Liver Regeneration
10/06/2025
Tuebingen, Germany, June 10, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver disease, today announced that the first patient has been dosed in [...]
Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site
10/06/2025
UHealth — University of Miami Health System and the University of Miami Miller School of Medicine provide world-class research and renowned clinical expertise in spine surgery CLARITY is a prospective, randomized [...]
Boehringer Ingelheim and Eko Health Inc. enter digital health collaboration to improve heart murmur detection in dogs
10/06/2025
A novel canine-specific detection algorithm is designed to improve early identification of heart disease and expand access to life-extending cardiac care for dogs Ingelheim, Germany, and San Francisco, Calif., June 10, [...]
Apothecare and FIKA Cannabis Partner to Deliver Pharmacist-Led Cannabis Consultations
10/06/2025
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Apothecare, Canada’s leading pharmacist-led cannabis consultation service, has partnered with FIKA Cannabis, one of the country’s fastest-growing lifestyle cannabis retailers, [...]
Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs
10/06/2025
Nation’s first CME-accredited course for APPs on clinical application of diagnostic biomarkers in Lung Nodule and Lung Cancer patient programs LOUISVILLE, Colo., June 10, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq [...]
Pharvaris Announces Annual Meeting of Shareholders
10/06/2025
ZUG, Switzerland, June 10, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living [...]

Pages